SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-017037
Filing Date
2024-05-15
Accepted
2024-05-15 16:01:57
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pirs20240331_10q.htm   iXBRL 10-Q 769870
2 EXHIBIT 10.2 ex_672912.htm EX-10.2 939831
3 EXHIBIT 10.3 ex_673179.htm EX-10.3 189569
4 EXHIBIT 31.1 ex_638158.htm EX-31.1 8574
5 EXHIBIT 31.2 ex_638159.htm EX-31.2 9278
6 EXHIBIT 32.1 ex_638160.htm EX-32.1 4241
7 EXHIBIT 32.2 ex_638161.htm EX-32.2 4222
  Complete submission text file 0001437749-24-017037.txt   5333556

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA pirs-20240331.xsd EX-101.SCH 41612
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pirs-20240331_cal.xml EX-101.CAL 26406
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20240331_def.xml EX-101.DEF 268867
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20240331_lab.xml EX-101.LAB 227610
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20240331_pre.xml EX-101.PRE 287136
63 EXTRACTED XBRL INSTANCE DOCUMENT pirs20240331_10q_htm.xml XML 508516
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 24950163
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)